Sometimes, US-based small startups find their evolving R&D plan, funding, or business collaborations make them suddenly ineligible for SBIR funding they had targeted. For example, clinical trial costs or even lab work would be cheaper overseas, so, just like that, eligibility slips away.
Have you turned your energies toward writing grants and articles while quarantined at home during the past few months? That’s wonderful—an efficient use of your valuable, limited time! After all, undisturbed writing time will be hard for you to find once your office or lab opens again. But, by that time, you will have articles and grants ready to submit, so you are ahead of the game!
Or are you? Because it is a safe bet that pretty much every other researcher has been spending their time the same way. Continue reading “Grant Strategies for 2020”